Year: 2019

Delårsrapport Q2ARCAROMA – augusti-oktober 2019Ökad marknadsaccept och orderingång för juiceCEPT® och oliveCEPT®Sammanfattning av andra kvartaletaugusti-oktober 2019Rörelsens intäkter uppgick till 2,8 (2,5) MSEK.EBITDA, rörelseresultat före avskrivningar, uppgick till -5,6 (-4,3) MSEK.Resultatet efter skatt uppgick till -9,2 (-4,4) MSEK.Totalresultatet uppgick till -12,2 (2,7) MSEK.Resultat per aktie före och efter utspädning uppgick till -0,81 (0,29) SEK.Med ”Bolaget”, ”ArcAroma” avses ArcAroma AB med organisationsnummer 556586 – 1985.   Väsentliga händelser under perioden Q2Avtal om uthyrning av en juiceCEPT® har tecknats med Frankly A/S, som är en dansk premiumtillverkare av ekologiska och kallpressade juicer. Avtalet löper på fem år med en option för kunden att köpa maskinen efter hyrestidens utgång.Avtal om uthyrning av en juiceCEPT®...

 Les exigences prudentielles de capital notifiées par la BCE restent inchangées pour 2020Le groupe Crédit Agricole et Crédit Agricole S.A. viennent d’être notifiés par la Banque Centrale Européenne (BCE) des exigences de capital applicables suite aux résultats du Processus de Revue et d’Evaluation de Supervision (« SREP »), confirmant les niveaux des exigences Pilier 2 (P2R) existants, soit 1,5% pour le groupe Crédit Agricole et pour Crédit Agricole S.A.Le groupe Crédit Agricole devra ainsi respecter un ratio CET1 minimum d’au moins 9,7% au 1er janvier 2020, incluant les exigences au titre du Pilier 1 et du Pilier 2, complétées de l’exigence globale de coussins de fonds propres en vigueur (coussin de conservation de 2,5%, coussin applicable aux établissements d’importance systémique de 1% et coussin contra-cyclique estimé à 20 pb au 1er...

 Unchanged ECB capital requirements for 2020The European Central Bank (ECB) has just notified Crédit Agricole Group and Crédit Agricole S.A. of their capital requirements following the completion of the Supervisory Review and Evaluation Process (SREP), confirming the current level of requirements in respect of Pillar 2 (P2R) i.e. 1.5% for Crédit Agricole Group and for Crédit Agricole S.A.Crédit Agricole Group must comply with a CET1 ratio of at least 9.7% from 1 January 2020, including Pillar 1 and Pillar 2 capital requirements as well as the applicable combined buffer requirement (conservation buffer of 2.5%, buffer for systemically important institutions of 1% and countercyclical buffer estimated at 20 bps as of 1 January 2020). Crédit Agricole S.A. must comply with a CET1 ratio of at least 8.7% from 1 January 2020, including Pillar...

           PRESS RELEASEPrada and L’Oréal announce the signing ofa long-term license agreementMilan and Clichy, 12 December 2019, 08.30 AM CET – Prada S.p.A. and L’Oréal announce the signing of a long-term license agreement for the creation, development and distribution of luxury beauty products for the Prada brand. This agreement will allow the two companies to combine their expertise in each of their own sectors.Patrizio Bertelli, CEO of Prada S.p.A.: “L’Oréal is the leading global beauty company. Its position and experience makes it the ideal partner for Prada to develop its full potential across a variety of new projects, leverage Prada’s well-established fragrance identity and reach even more audiences around the world.”Cyril Chapuy, President of L’Oréal Luxe: “We are very pleased to have signed this license...

FALCON OIL & GAS LTD.(“Falcon”)Results of Annual General & Special Shareholders Meeting12 December 2019 – Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) held its Annual General & Special Shareholders meeting in Dublin, Ireland yesterday.All resolutions considered and voted upon by the shareholders were approved. The full text of each resolution was included in the Management Information Circular communicated in advance of the meeting to shareholders.For further information, please contact:CONTACT DETAILS:About Falcon Oil & Gas Ltd.Falcon Oil & Gas Ltd is an international oil & gas company engaged in the exploration and development of unconventional oil and gas assets, with the current portfolio focused in Australia, South Africa and Hungary. Falcon Oil & Gas Ltd is incorporated in British Columbia,...

Oxford Technology VCT Plc presents its quarterly update for the 3 month period commencing 1 September 2019. The Directors have recently reviewed the valuation of its entire portfolio as at 30 November 2019, the make-up of which did not change during the quarter.The unaudited net asset value per ordinary share as at 30 November 2019 was 43.9p. This represents a decrease of 5.6p from the net asset value per ordinary share at 31 August 2019. This decrease is attributable to the drop in share price of Scancell (6.8p to 4.8p) as well as a decrease in the valuation of Getmapping and Select.The total return to shareholders including previous dividends of 55.0p per share is now 98.9p per share.The total number of ordinary shares in issue is 5,431,655.The Directors are not aware of any other events or transactions which have taken place between...

With its Prima system, Pixium Vision is bringing breakthrough technologies to people suffering from dry Age-related Macular DegenerationParis, France, December 12, 2019 – 08:00 am CET – Pixium Vision (FR0011950641 – PIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, was a finalist in the Paris 2040 award in the Paris Innovation Grand Prix, which recognizes the commitment of companies to addressing societal challenges.The aim of the Paris Innovation Grand Prix (Grands Prix de I’Innovation de la Ville de Paris) is to support the development of innovative companies in fast-growing sectors in the Paris area. The Paris 2040 category awards companies who are rethinking the city of the future with a focus on the environment and people...

Avec le Système Prima, Pixium Vision apporte une technologie de rupture aux personnes atteintes de forme sèche de Dégénérescence Maculaire liée à l’AgeParis, France, 12 Décembre 2019 – 08:00 CET – Pixium Vision (FR0011950641 – PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue de vivre de façon plus autonome, a été retenu parmi les finalistes des Grands Prix de la Ville de Paris, dans la catégorie Paris 2040, qui récompense l’engagement des entreprises face aux défis sociétauxLes Grands Prix de I’Innovation de la Ville de Paris ont pour vocation de soutenir le développement des entreprises innovantes franciliennes dans des secteurs en forte croissance. La catégorie Paris 2040 récompense les Sociétés porteuses de projets novateurs à fort impact...

Oslo, Norway, December 12, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present results from the successful fimaVacc Phase I proof of concept study in healthy volunteers at the ESMO Immuno-Oncology Congress 2019 being held December 11-14, 2019 at Palexpo in Geneva, Switzerland.PCI Biotech’s research collaborator, Oslo University Hospital represented by Dr. Pål Selbo, will present the poster during the poster display session Thursday, December 12, from 12:15 to 13:15 local time (CET). The presented results provide proof of concept of the fimaVacc vaccination technology by demonstrating the improvement of immunogenicity in a healthy volunteer study completed in May 2019.The poster named “109P – Phase I clinical study...